Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Rising High: Exclusive talk with cannabis company TYSON 2.0 » 11:01
09/15/22
09/15
11:01
09/15/22
11:01
RLMD

Relmada Therapeutics

$33.46 /

+0.36 (+1.09%)

, CMPS

Compass Pathways

$14.25 /

+0.15 (+1.06%)

, ATAI

Atai Life Sciences

$4.05 /

+0.055 (+1.38%)

, CCHWF

Columbia Care

$1.72 /

+0.02 (+1.18%)

, VRNOF

Verano Holdings

$5.72 /

+0.08 (+1.42%)

, HEXO

Hexo

/

+

, ZYNE

Zynerba

$1.15 /

+0.02 (+1.77%)

, TCNNF

Trulieve Cannabis

$11.84 /

-0.23 (-1.91%)

, TLRY

Tilray

$3.45 /

+0.07 (+2.07%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$11.50 /

+0.17 (+1.50%)

, GDNSF

Goodness Growth

$1.18 /

+0.015 (+1.29%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.20 /

+0.095 (+3.06%)

, CGC

Canopy Growth

$3.49 /

+0.015 (+0.43%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$1.55 /

+0.015 (+0.98%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
$1.15 /

+0.02 (+1.77%)

VRNOF Verano Holdings
$5.72 /

+0.08 (+1.42%)

TLRY Tilray
$3.45 /

+0.07 (+2.07%)

TCNNF Trulieve Cannabis
$11.84 /

-0.23 (-1.91%)

RLMD Relmada Therapeutics
$33.46 /

+0.36 (+1.09%)

IGC India Globalization Capital
/

+

HEXO Hexo
/

+

GTBIF Green Thumb Industries
$11.50 /

+0.17 (+1.50%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.20 /

+0.095 (+3.06%)

CMPS Compass Pathways
$14.25 /

+0.15 (+1.06%)

CGC Canopy Growth
$3.49 /

+0.015 (+0.43%)

CCHWF Columbia Care
$1.72 /

+0.02 (+1.18%)

ATAI Atai Life Sciences
$4.05 /

+0.055 (+1.38%)

ACB Aurora Cannabis
$1.55 /

+0.015 (+0.98%)

RLMD Relmada Therapeutics
$33.46 /

+0.36 (+1.09%)

09/06/22 Guggenheim
Relmada Therapeutics price target raised to $60 from $50 at Guggenheim
05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Securities
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
CMPS Compass Pathways
$14.25 /

+0.15 (+1.06%)

08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
08/05/22 Citi
Compass Pathways price target lowered to $46 from $49 at Citi
02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
ATAI Atai Life Sciences
$4.05 /

+0.055 (+1.38%)

09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
CCHWF Columbia Care
$1.72 /

+0.02 (+1.18%)

08/15/22 Alliance Global Partners
Columbia Care price target lowered to C$5 from C$8 at Alliance Global Partners
05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
VRNOF Verano Holdings
$5.72 /

+0.08 (+1.42%)

09/08/22 PI Financial
Verano Holdings initiated with a Buy at PI Financial
08/16/22 Alliance Global Partners
Verano Holdings price target lowered to C$16 from C$27 at Alliance Global Partners
07/29/22 Needham
Verano Holdings cut to Hold at Needham on unresolved financial reporting issues
07/29/22 Needham
Verano Holdings downgraded to Hold from Buy at Needham
HEXO Hexo
/

+

06/16/22 Canaccord
Hexo downgraded to Hold at Canaccord on faltering turnaround prospects
06/15/22 Canaccord
Hexo downgraded to Hold from Speculative Buy at Canaccord
06/15/22 Alliance Global Partners
Hexo downgraded to Neutral from Buy at Alliance Global Partners
06/15/22 Canaccord
Tilray price target lowered to $7 from $9 at CanaccordHexo
ZYNE Zynerba
$1.15 /

+0.02 (+1.77%)

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
TCNNF Trulieve Cannabis
$11.84 /

-0.23 (-1.91%)

08/11/22 Canaccord
Trulieve Cannabis price target lowered to C$57 from C$65 at Canaccord
08/11/22 Stifel
Trulieve Cannabis price target lowered to C$36.50 from C$40 at Stifel
08/11/22 Craig-Hallum
Trulieve Cannabis price target lowered to $32 from $40 at Craig-Hallum
08/11/22 Cowen
Trulieve Cannabis price target lowered to $24 from $65 at Cowen
TLRY Tilray
$3.45 /

+0.07 (+2.07%)

07/29/22 Cowen
Tilray price target lowered to $9 from $23 at Cowen
07/29/22 Benchmark
Tilray cut to Sell at Benchmark on continued deterioration in core business
07/29/22 Benchmark
Tilray downgraded to Sell from Hold at Benchmark
07/15/22 Roth Capital
Tilray price target lowered to $4 from $8 at Roth Capital
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.50 /

+0.17 (+1.50%)

08/04/22 Canaccord
Green Thumb Industries price target lowered to C$35 from C$40 at Canaccord
08/04/22 Stifel
Green Thumb Industries price target raised to C$30.50 from C$30 at Stifel
08/04/22 Alliance Global Partners
Green Thumb Industries price target lowered to C$25 at Alliance Global Partners
08/04/22 Cantor Fitzgerald
Green Thumb Industries price target lowered to $31 from $39 at Cantor Fitzgerald
GDNSF Goodness Growth
$1.18 /

+0.015 (+1.29%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
CANN General Cannabis
/

+

CRON Cronos Group
$3.20 /

+0.095 (+3.06%)

07/28/22 Canaccord
Cronos Group upgraded to Buy from Hold at Canaccord
05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
CGC Canopy Growth
$3.49 /

+0.015 (+0.43%)

08/08/22 Canaccord
Canopy Growth price target lowered to C$2.75 from C$3.50 at Canaccord
08/08/22 Piper Sandler
Canopy Growth price target lowered to $2.50 from $3 at Piper Sandler
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$1.55 /

+0.015 (+0.98%)

06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
06/24/22 Cantor Fitzgerald
Aurora Cannabis upgraded to Overweight from Neutral at Cantor Fitzgerald
06/06/22 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
ZYNE Zynerba
$1.15 /

+0.02 (+1.77%)

VRNOF Verano Holdings
$5.72 /

+0.08 (+1.42%)

TLRY Tilray
$3.45 /

+0.07 (+2.07%)

TCNNF Trulieve Cannabis
$11.84 /

-0.23 (-1.91%)

RLMD Relmada Therapeutics
$33.46 /

+0.36 (+1.09%)

HEXO Hexo
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.20 /

+0.095 (+3.06%)

CMPS Compass Pathways
$14.25 /

+0.15 (+1.06%)

CGC Canopy Growth
$3.49 /

+0.015 (+0.43%)

ATAI Atai Life Sciences
$4.05 /

+0.055 (+1.38%)

ACB Aurora Cannabis
$1.55 /

+0.015 (+0.98%)

  • 27
    May
  • 09
    Dec
ZYNE Zynerba
$1.15 /

+0.02 (+1.77%)

RLMD Relmada Therapeutics
$33.46 /

+0.36 (+1.09%)

HEXO Hexo
/

+

CRON Cronos Group
$3.20 /

+0.095 (+3.06%)

CCHWF Columbia Care
$1.72 /

+0.02 (+1.18%)

TLRY Tilray
$3.45 /

+0.07 (+2.07%)

HEXO Hexo
/

+

CRON Cronos Group
$3.20 /

+0.095 (+3.06%)

CGC Canopy Growth
$3.49 /

+0.015 (+0.43%)

ACB Aurora Cannabis
$1.55 /

+0.015 (+0.98%)

Over a month ago
On The Fly
Here's What You Missed in Cannabis This Week » 12:00
08/25/22
08/25
12:00
08/25/22
12:00
ZYNE

Zynerba

$1.22 /

+0.02 (+1.67%)

, TCNNF

Trulieve Cannabis

$13.44 /

+1.08 (+8.74%)

, TLRY

Tilray

$3.82 /

+0.065 (+1.73%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$12.36 /

+0.8299 (+7.20%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.17 /

+0.075 (+2.42%)

, CGC

Canopy Growth

$3.88 /

+ (+0.00%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, RLMD

Relmada Therapeutics

$32.12 /

-0.03 (-0.09%)

, CMPS

Compass Pathways

$18.29 /

+0.09 (+0.49%)

, ATAI

Atai Life Sciences

$4.79 /

+0.13 (+2.79%)

, GDNSF

Goodness Growth

$1.35 /

+0.15 (+12.50%)

, CCHWF

Columbia Care

$1.96 /

+0.2 (+11.36%)

, MMNFF

MedMen

/

+

, ACB

Aurora Cannabis

$1.54 /

-0.02 (-1.29%)

, VLNS

Valens

/

+

, SNDL

Sundial Growers

$2.75 /

-0.04 (-1.43%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$1.22 /

+0.02 (+1.67%)

VLNS Valens
/

+

TLRY Tilray
$3.82 /

+0.065 (+1.73%)

TCNNF Trulieve Cannabis
$13.44 /

+1.08 (+8.74%)

SNDL Sundial Growers
$2.75 /

-0.04 (-1.43%)

RLMD Relmada Therapeutics
$32.12 /

-0.03 (-0.09%)

MMNFF MedMen
/

+

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$12.36 /

+0.8299 (+7.20%)

GDNSF Goodness Growth
$1.35 /

+0.15 (+12.50%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.17 /

+0.075 (+2.42%)

CMPS Compass Pathways
$18.29 /

+0.09 (+0.49%)

CGC Canopy Growth
$3.88 /

+ (+0.00%)

CCHWF Columbia Care
$1.96 /

+0.2 (+11.36%)

ATAI Atai Life Sciences
$4.79 /

+0.13 (+2.79%)

ACB Aurora Cannabis
$1.54 /

-0.02 (-1.29%)

ZYNE Zynerba
$1.22 /

+0.02 (+1.67%)

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
TCNNF Trulieve Cannabis
$13.44 /

+1.08 (+8.74%)

08/11/22 Canaccord
Trulieve Cannabis price target lowered to C$57 from C$65 at Canaccord
08/11/22 Stifel
Trulieve Cannabis price target lowered to C$36.50 from C$40 at Stifel
08/11/22 Craig-Hallum
Trulieve Cannabis price target lowered to $32 from $40 at Craig-Hallum
08/11/22 Cowen
Trulieve Cannabis price target lowered to $24 from $65 at Cowen
TLRY Tilray
$3.82 /

+0.065 (+1.73%)

07/29/22 Cowen
Tilray price target lowered to $9 from $23 at Cowen
07/29/22 Benchmark
Tilray cut to Sell at Benchmark on continued deterioration in core business
07/29/22 Benchmark
Tilray downgraded to Sell from Hold at Benchmark
07/15/22 Roth Capital
Tilray price target lowered to $4 from $8 at Roth Capital
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$12.36 /

+0.8299 (+7.20%)

08/04/22 Canaccord
Green Thumb Industries price target lowered to C$35 from C$40 at Canaccord
08/04/22 Stifel
Green Thumb Industries price target raised to C$30.50 from C$30 at Stifel
08/04/22 Alliance Global Partners
Green Thumb Industries price target lowered to C$25 at Alliance Global Partners
08/04/22 Cantor Fitzgerald
Green Thumb Industries price target lowered to $31 from $39 at Cantor Fitzgerald
CANN General Cannabis
/

+

CRON Cronos Group
$3.17 /

+0.075 (+2.42%)

07/28/22 Canaccord
Cronos Group upgraded to Buy from Hold at Canaccord
05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
CGC Canopy Growth
$3.88 /

+ (+0.00%)

08/08/22 Canaccord
Canopy Growth price target lowered to C$2.75 from C$3.50 at Canaccord
08/08/22 Piper Sandler
Canopy Growth price target lowered to $2.50 from $3 at Piper Sandler
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
CTST CannTrust
/

+

CVSI CV Sciences
/

+

RLMD Relmada Therapeutics
$32.12 /

-0.03 (-0.09%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Securities
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
CMPS Compass Pathways
$18.29 /

+0.09 (+0.49%)

08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
08/05/22 Citi
Compass Pathways price target lowered to $46 from $49 at Citi
02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
ATAI Atai Life Sciences
$4.79 /

+0.13 (+2.79%)

05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
GDNSF Goodness Growth
$1.35 /

+0.15 (+12.50%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
CCHWF Columbia Care
$1.96 /

+0.2 (+11.36%)

08/15/22 Alliance Global Partners
Columbia Care price target lowered to C$5 from C$8 at Alliance Global Partners
05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
MMNFF MedMen
/

+

01/04/22 Needham
Ascend Wellness price target lowered to $11 from $13 at Needham
11/11/21 Canaccord
MedMen price target lowered to C$0.35 from C$0.40 at Canaccord
09/24/21 Canaccord
MedMen upgraded to Hold from Sell at Canaccord
ACB Aurora Cannabis
$1.54 /

-0.02 (-1.29%)

06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
06/24/22 Cantor Fitzgerald
Aurora Cannabis upgraded to Overweight from Neutral at Cantor Fitzgerald
06/06/22 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
VLNS Valens
/

+

08/23/22 Stifel
Valens price target lowered to C$1.20 from C$3.50 at Stifel
07/20/22 Raymond James
Valens price target lowered to C$1 from C$2.50 at Raymond James
07/15/22 Canaccord
Valens price target lowered to C$4 from C$6.75 at Canaccord
07/15/22 Stifel
Valens price target lowered to C$3.50 from C$4.50 at Stifel
SNDL Sundial Growers
$2.75 /

-0.04 (-1.43%)

08/16/22 Canaccord
Sundial Growers upgraded to Speculative Buy from Hold at Canaccord
05/03/22 BMO Capital
Sundial Growers upgraded to Market Perform from Underperform at BMO Capital
05/03/22 BMO Capital
Sundial Growers upgraded to Market Perform from Underperform at BMO Capital
ZYNE Zynerba
$1.22 /

+0.02 (+1.67%)

VLNS Valens
/

+

TLRY Tilray
$3.82 /

+0.065 (+1.73%)

TCNNF Trulieve Cannabis
$13.44 /

+1.08 (+8.74%)

SNDL Sundial Growers
$2.75 /

-0.04 (-1.43%)

RLMD Relmada Therapeutics
$32.12 /

-0.03 (-0.09%)

GTBIF Green Thumb Industries
$12.36 /

+0.8299 (+7.20%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.17 /

+0.075 (+2.42%)

CMPS Compass Pathways
$18.29 /

+0.09 (+0.49%)

CGC Canopy Growth
$3.88 /

+ (+0.00%)

ATAI Atai Life Sciences
$4.79 /

+0.13 (+2.79%)

ACB Aurora Cannabis
$1.54 /

-0.02 (-1.29%)

  • 27
    May
  • 09
    Dec
ZYNE Zynerba
$1.22 /

+0.02 (+1.67%)

ZYNE Zynerba
$1.22 /

+0.02 (+1.67%)

VLNS Valens
/

+

TLRY Tilray
$3.82 /

+0.065 (+1.73%)

MMNFF MedMen
/

+

CRON Cronos Group
$3.17 /

+0.075 (+2.42%)

CCHWF Columbia Care
$1.96 /

+0.2 (+11.36%)

TLRY Tilray
$3.82 /

+0.065 (+1.73%)

SNDL Sundial Growers
$2.75 /

-0.04 (-1.43%)

CRON Cronos Group
$3.17 /

+0.075 (+2.42%)

CGC Canopy Growth
$3.88 /

+ (+0.00%)

ACB Aurora Cannabis
$1.54 /

-0.02 (-1.29%)

On The Fly
Here's What You Missed in Cannabis This Week » 12:54
08/18/22
08/18
12:54
08/18/22
12:54
CANN

General Cannabis

/

+

, GTBIF

Green Thumb Industries

$10.47 /

-0.6 (-5.42%)

, CCHWF

Columbia Care

$1.82 /

-0.06 (-3.19%)

, FLGC

Flora Growth

/

+

, CVSI

CV Sciences

/

+

, DLTNF

Delta 9 Cannabis

/

+

, IMCC

IM Cannabis

/

+

, MEDIF

Medipharm Labs

/

+

, FFNTF

4Front Ventures

/

+

, INCR

InterCure

$5.78 /

-0.04 (-0.69%)

, NEPT

Neptune Wellness

$3.07 /

+1.71 (+125.74%)

, PLNHF

Planet 13 Holdings

$1.69 /

-0.1 (-5.59%)

, GNLN

Greenlane

$3.45 /

-0.13 (-3.63%)

, NDVAF

INDIVA

/

+

, VRNOF

Verano Holdings

$5.61 /

-0.09 (-1.58%)

, CRLBF

Cresco Labs

$3.63 /

-0.12 (-3.20%)

, AYRWF

Ayr Wellness

$4.54 /

-0.09325 (-2.01%)

, ATAI

Atai Life Sciences

$4.61 /

+0.09 (+1.99%)

, RVLWF

Revitalist Lifestyle and Wellness

/

+

, AWKNF

Awakn Life Sciences

/

+

, TLRY

Tilray

$3.95 /

-0.105 (-2.59%)

, ACB

Aurora Cannabis

$1.66 /

-0.08 (-4.60%)

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$3.80 /

-0.27 (-6.64%)

, CRON

Cronos Group

$3.10 /

-0.105 (-3.28%)

, IGC

India Globalization Capital

/

+

, TCNNF

Trulieve Cannabis

$12.81 /

-0.38 (-2.88%)

, ZYNE

Zynerba

$1.24 /

-0.075 (-5.70%)

, CMPS

Compass Pathways

$16.95 /

-0.02 (-0.12%)

, RLMD

Relmada Therapeutics

$27.56 /

-0.52 (-1.85%)

, GDNSF

Goodness Growth

$1.11 /

-0.033 (-2.89%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$1.24 /

-0.075 (-5.70%)

VRNOF Verano Holdings
$5.61 /

-0.09 (-1.58%)

TLRY Tilray
$3.95 /

-0.105 (-2.59%)

TCNNF Trulieve Cannabis
$12.81 /

-0.38 (-2.88%)

RVLWF Revitalist Lifestyle and Wellness
/

+

RLMD Relmada Therapeutics
$27.56 /

-0.52 (-1.85%)

PLNHF Planet 13 Holdings
$1.69 /

-0.1 (-5.59%)

NEPT Neptune Wellness
$3.07 /

+1.71 (+125.74%)

MEDIF Medipharm Labs
/

+

INCR InterCure
$5.78 /

-0.04 (-0.69%)

IMCC IM Cannabis
/

+

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$10.47 /

-0.6 (-5.42%)

GNLN Greenlane
$3.45 /

-0.13 (-3.63%)

GDNSF Goodness Growth
$1.11 /

-0.033 (-2.89%)

FLGC Flora Growth
/

+

DLTNF Delta 9 Cannabis
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.10 /

-0.105 (-3.28%)

CMPS Compass Pathways
$16.95 /

-0.02 (-0.12%)

CGC Canopy Growth
$3.80 /

-0.27 (-6.64%)

CCHWF Columbia Care
$1.82 /

-0.06 (-3.19%)

AYRWF Ayr Wellness
$4.54 /

-0.09325 (-2.01%)

ATAI Atai Life Sciences
$4.61 /

+0.09 (+1.99%)

ACB Aurora Cannabis
$1.66 /

-0.08 (-4.60%)

CANN General Cannabis
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
GTBIF Green Thumb Industries
$10.47 /

-0.6 (-5.42%)

08/04/22 Canaccord
Green Thumb Industries price target lowered to C$35 from C$40 at Canaccord
08/04/22 Stifel
Green Thumb Industries price target raised to C$30.50 from C$30 at Stifel
08/04/22 Alliance Global Partners
Green Thumb Industries price target lowered to C$25 at Alliance Global Partners
08/04/22 Cantor Fitzgerald
Green Thumb Industries price target lowered to $31 from $39 at Cantor Fitzgerald
CCHWF Columbia Care
$1.82 /

-0.06 (-3.19%)

08/15/22 Alliance Global Partners
Columbia Care price target lowered to C$5 from C$8 at Alliance Global Partners
05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
FLGC Flora Growth
/

+

08/01/22 Cantor Fitzgerald
Cantor starts Flora Growth with Neutral amid diversification process
08/01/22 Cantor Fitzgerald
Flora Growth initiated with a Neutral at Cantor Fitzgerald
06/16/22 Roth Capital
Roth Capital views Flora Growth $5M share buyback 'favorably'
10/13/21 Roth Capital
Flora Growth initiated with a Buy at Roth Capital
CVSI CV Sciences
/

+

DLTNF Delta 9 Cannabis
/

+

IMCC IM Cannabis
/

+

08/16/22 Alliance Global Partners
IM Cannabis price target lowered to $1.50 from $6 at Alliance Global Partners
11/17/21 Desjardins
IM Cannabis price target lowered to C$9.25 from C$10.25 at Desjardins
10/05/21 Roth Capital
IM Cannabis initiated with a Buy at Roth Capital
MEDIF Medipharm Labs
/

+

05/17/22 Canaccord
Medipharm Labs price target lowered to C$0.10 from C$0.20 at Canaccord
04/04/22 Canaccord
Medipharm Labs price target lowered to C$0.20 from C$0.35 at Canaccord
04/01/22 Alliance Global Partners
Medipharm Labs price target lowered to C$0.25 from C$0.35 at Alliance Global Partners
11/16/21 Canaccord
Medipharm Labs downgraded to Hold from Speculative Buy at Canaccord
FFNTF 4Front Ventures
/

+

INCR InterCure
$5.78 /

-0.04 (-0.69%)

05/17/22 Canaccord
InterCure upgraded to Buy from Speculative Buy at Canaccord
NEPT Neptune Wellness
$3.07 /

+1.71 (+125.74%)

07/01/22 Alliance Global Partners
Neptune Wellness downgraded to Neutral from Buy at Alliance Global Partners
11/17/21 Desjardins
Neptune Wellness price target lowered to C$0.75 from C$1.00 at Desjardins
PLNHF Planet 13 Holdings
$1.69 /

-0.1 (-5.59%)

GNLN Greenlane
$3.45 /

-0.13 (-3.63%)

08/17/22 Alliance Global Partners
Greenlane price target raised to $6 from $1.50 at Alliance Global Partners
08/17/22 Canaccord
Greenlane price target lowered to $5 from $20 at Canaccord
04/01/22 Canaccord
Greenlane price target lowered to $1 from $2 at Canaccord
04/01/22 Cowen
Greenlane price target lowered to $2 from $5 at Cowen
NDVAF INDIVA
/

+

04/21/22 Raymond James
INDIVA price target lowered to C$0.60 from C$1.25 at Raymond James
10/15/21 Raymond James
INDIVA downgraded to Outperform from Strong Buy at Raymond James
VRNOF Verano Holdings
$5.61 /

-0.09 (-1.58%)

08/16/22 Alliance Global Partners
Verano Holdings price target lowered to C$16 from C$27 at Alliance Global Partners
07/29/22 Needham
Verano Holdings cut to Hold at Needham on unresolved financial reporting issues
07/29/22 Needham
Verano Holdings downgraded to Hold from Buy at Needham
07/22/22 Seaport Global
Verano Holdings initiated with a Buy at Seaport Global
CRLBF Cresco Labs
$3.63 /

-0.12 (-3.20%)

08/18/22 Canaccord
Cresco Labs price target lowered to C$8 from C$9.50 at Canaccord
08/18/22 Piper Sandler
Cresco Labs price target lowered to $6 from $9 at Piper Sandler
08/17/22 Alliance Global Partners
Cresco Labs price target lowered to C$10 from C$15 at Alliance Global Partners
05/19/22 Canaccord
Cresco Labs price target lowered to C$9.50 from C$12 at Canaccord
AYRWF Ayr Wellness
$4.54 /

-0.09325 (-2.01%)

07/22/22 Seaport Global
Ayr Wellness initiated with a Buy at Seaport Global
03/18/22 Canaccord
Ayr Wellness price target lowered to C$40 from C$57 at Canaccord
03/03/22 Needham
Ayr Wellness price target lowered to $28 from $35 at Needham
12/20/21 Needham
Ayr Wellness named Cannabis Top Pick for 2022 at Needham
ATAI Atai Life Sciences
$4.61 /

+0.09 (+1.99%)

05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
RVLWF Revitalist Lifestyle and Wellness
/

+

05/03/22 Clarus
Revitalist Lifestyle and Wellness price target lowered to C$0.20 at Clarus
10/25/21 Clarus
Revitalist Lifestyle and Wellness initiated with a Speculative Buy at Clarus
AWKNF Awakn Life Sciences
/

+

04/01/22 Stifel
Awakn Life Sciences initiated with a Speculative Buy at Stifel
02/01/22 H.C. Wainwright
Awakn Life Sciences initiated with a Buy at H.C. Wainwright
TLRY Tilray
$3.95 /

-0.105 (-2.59%)

07/29/22 Cowen
Tilray price target lowered to $9 from $23 at Cowen
07/29/22 Benchmark
Tilray cut to Sell at Benchmark on continued deterioration in core business
07/29/22 Benchmark
Tilray downgraded to Sell from Hold at Benchmark
07/15/22 Roth Capital
Tilray price target lowered to $4 from $8 at Roth Capital
ACB Aurora Cannabis
$1.66 /

-0.08 (-4.60%)

06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
06/24/22 Cantor Fitzgerald
Aurora Cannabis upgraded to Overweight from Neutral at Cantor Fitzgerald
06/06/22 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
CTST CannTrust
/

+

CGC Canopy Growth
$3.80 /

-0.27 (-6.64%)

08/08/22 Canaccord
Canopy Growth price target lowered to C$2.75 from C$3.50 at Canaccord
08/08/22 Piper Sandler
Canopy Growth price target lowered to $2.50 from $3 at Piper Sandler
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
CRON Cronos Group
$3.10 /

-0.105 (-3.28%)

07/28/22 Canaccord
Cronos Group upgraded to Buy from Hold at Canaccord
05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
IGC India Globalization Capital
/

+

TCNNF Trulieve Cannabis
$12.81 /

-0.38 (-2.88%)

08/11/22 Canaccord
Trulieve Cannabis price target lowered to C$57 from C$65 at Canaccord
08/11/22 Stifel
Trulieve Cannabis price target lowered to C$36.50 from C$40 at Stifel
08/11/22 Craig-Hallum
Trulieve Cannabis price target lowered to $32 from $40 at Craig-Hallum
08/11/22 Cowen
Trulieve Cannabis price target lowered to $24 from $65 at Cowen
ZYNE Zynerba
$1.24 /

-0.075 (-5.70%)

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
CMPS Compass Pathways
$16.95 /

-0.02 (-0.12%)

08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
08/05/22 Citi
Compass Pathways price target lowered to $46 from $49 at Citi
02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
RLMD Relmada Therapeutics
$27.56 /

-0.52 (-1.85%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Securities
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
GDNSF Goodness Growth
$1.11 /

-0.033 (-2.89%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
ZYNE Zynerba
$1.24 /

-0.075 (-5.70%)

VRNOF Verano Holdings
$5.61 /

-0.09 (-1.58%)

TLRY Tilray
$3.95 /

-0.105 (-2.59%)

TCNNF Trulieve Cannabis
$12.81 /

-0.38 (-2.88%)

RLMD Relmada Therapeutics
$27.56 /

-0.52 (-1.85%)

PLNHF Planet 13 Holdings
$1.69 /

-0.1 (-5.59%)

INCR InterCure
$5.78 /

-0.04 (-0.69%)

IMCC IM Cannabis
/

+

GTBIF Green Thumb Industries
$10.47 /

-0.6 (-5.42%)

GNLN Greenlane
$3.45 /

-0.13 (-3.63%)

FLGC Flora Growth
/

+

DLTNF Delta 9 Cannabis
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.10 /

-0.105 (-3.28%)

CMPS Compass Pathways
$16.95 /

-0.02 (-0.12%)

CGC Canopy Growth
$3.80 /

-0.27 (-6.64%)

AYRWF Ayr Wellness
$4.54 /

-0.09325 (-2.01%)

ATAI Atai Life Sciences
$4.61 /

+0.09 (+1.99%)

ACB Aurora Cannabis
$1.66 /

-0.08 (-4.60%)

  • 27
    May
  • 09
    Dec
  • 19
    Nov
CANN General Cannabis
/

+

TLRY Tilray
$3.95 /

-0.105 (-2.59%)

TCNNF Trulieve Cannabis
$12.81 /

-0.38 (-2.88%)

INCR InterCure
$5.78 /

-0.04 (-0.69%)

FLGC Flora Growth
/

+

FFNTF 4Front Ventures
/

+

DLTNF Delta 9 Cannabis
/

+

CRON Cronos Group
$3.10 /

-0.105 (-3.28%)

CRLBF Cresco Labs
$3.63 /

-0.12 (-3.20%)

CCHWF Columbia Care
$1.82 /

-0.06 (-3.19%)

CANN General Cannabis
/

+

AYRWF Ayr Wellness
$4.54 /

-0.09325 (-2.01%)

AWKNF Awakn Life Sciences
/

+

TLRY Tilray
$3.95 /

-0.105 (-2.59%)

CRON Cronos Group
$3.10 /

-0.105 (-3.28%)

CGC Canopy Growth
$3.80 /

-0.27 (-6.64%)

ACB Aurora Cannabis
$1.66 /

-0.08 (-4.60%)

Recommendations
Columbia Care price target lowered to C$5 from C$8 at Alliance Global Partners » 16:18
08/15/22
08/15
16:18
08/15/22
16:18
CCHWF

Columbia Care

$1.77 /

+0.04 (+2.31%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey lowered the firm's price target on Columbia Care to C$5 from C$8 and keeps a Buy rating on the shares after the company reported sales below his and Street estimates and lowered its implied sales guidance. While Columbia Care "over-indexing" to legacy mature adult-use markets like Colorado and California has weighed on performance, he is still bullish on the company's long-term prospects given new states ramping and beginning adult-use sales, Grey tells investors.

ShowHide Related Items >><<
CCHWF Columbia Care
$1.77 /

+0.04 (+2.31%)

CCHWF Columbia Care
$1.77 /

+0.04 (+2.31%)

05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
CCHWF Columbia Care
$1.77 /

+0.04 (+2.31%)

On The Fly
Here's What You Missed in Cannabis This Week » 11:15
08/04/22
08/04
11:15
08/04/22
11:15
ETRGF

Entourage Health

/

+

, CCHWF

Columbia Care

$1.76 /

+0.015 (+0.86%)

, LOVFF

Cannara Biotech

/

+

, FLGC

Flora Growth

/

+

, CLVR

Clever Leaves

$1.01 /

+ (+0.00%)

, ACB

Aurora Cannabis

$1.53 /

-0.015 (-0.97%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$2.84 /

-0.065 (-2.24%)

, CRON

Cronos Group

$3.39 /

-0.05 (-1.46%)

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

$1.11 /

-0.0201 (-1.78%)

, GTBIF

Green Thumb Industries

$9.71 /

+0.13 (+1.36%)

, IGC

India Globalization Capital

/

+

, TLRY

Tilray

$3.85 /

-0.03 (-0.77%)

, TCNNF

Trulieve Cannabis

$13.30 /

-0.15 (-1.12%)

, ZYNE

Zynerba

$1.22 /

+0.06 (+5.17%)

, ATAI

Atai Life Sciences

$4.10 /

+0.095 (+2.37%)

, CMPS

Compass Pathways

$17.01 /

+0.93 (+5.78%)

, RLMD

Relmada Therapeutics

$24.85 /

+0.22 (+0.89%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$1.22 /

+0.06 (+5.17%)

TLRY Tilray
$3.85 /

-0.03 (-0.77%)

TCNNF Trulieve Cannabis
$13.30 /

-0.15 (-1.12%)

RLMD Relmada Therapeutics
$24.85 /

+0.22 (+0.89%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$9.71 /

+0.13 (+1.36%)

GDNSF Goodness Growth
$1.11 /

-0.0201 (-1.78%)

FLGC Flora Growth
/

+

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.39 /

-0.05 (-1.46%)

CMPS Compass Pathways
$17.01 /

+0.93 (+5.78%)

CLVR Clever Leaves
$1.01 /

+ (+0.00%)

CGC Canopy Growth
$2.84 /

-0.065 (-2.24%)

CCHWF Columbia Care
$1.76 /

+0.015 (+0.86%)

ATAI Atai Life Sciences
$4.10 /

+0.095 (+2.37%)

ACB Aurora Cannabis
$1.53 /

-0.015 (-0.97%)

ETRGF Entourage Health
/

+

06/02/22 Canaccord
Entourage Health downgraded to Hold from Speculative Buy at Canaccord
11/18/21 Canaccord
Entourage Health price target lowered to C$0.40 from C$0.60 at Canaccord
11/17/21 Canaccord
Entourage Health price target lowered to C$0.40 from C$0.60 at Canaccord
CCHWF Columbia Care
$1.76 /

+0.015 (+0.86%)

05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
LOVFF Cannara Biotech
/

+

FLGC Flora Growth
/

+

08/01/22 Cantor Fitzgerald
Cantor starts Flora Growth with Neutral amid diversification process
08/01/22 Cantor Fitzgerald
Flora Growth initiated with a Neutral at Cantor Fitzgerald
06/16/22 Roth Capital
Roth Capital views Flora Growth $5M share buyback 'favorably'
10/13/21 Roth Capital
Flora Growth initiated with a Buy at Roth Capital
CLVR Clever Leaves
$1.01 /

+ (+0.00%)

08/01/22 Cantor Fitzgerald
Cantor starts Clever Leaves at Overweight for overseas medical cannabis exposure
08/01/22 Cantor Fitzgerald
Clever Leaves initiated with an Overweight at Cantor Fitzgerald
05/13/22 Canaccord
Clever Leaves price target lowered to $4 from $7 at Canaccord
03/28/22 Cowen
Clever Leaves price target lowered to $4 from $6 at Cowen
ACB Aurora Cannabis
$1.53 /

-0.015 (-0.97%)

06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
06/24/22 Cantor Fitzgerald
Aurora Cannabis upgraded to Overweight from Neutral at Cantor Fitzgerald
06/06/22 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
CVSI CV Sciences
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CTST CannTrust
/

+

CGC Canopy Growth
$2.84 /

-0.065 (-2.24%)

07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
06/30/22 Piper Sandler
Canopy Growth price target lowered to $3 from $4 at Piper Sandler
06/29/22 MKM Partners
Canopy Growth price target lowered to C$13 from C$17 at MKM Partners
CRON Cronos Group
$3.39 /

-0.05 (-1.46%)

07/28/22 Canaccord
Cronos Group upgraded to Buy from Hold at Canaccord
05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
CANN General Cannabis
/

+

GDNSF Goodness Growth
$1.11 /

-0.0201 (-1.78%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
GTBIF Green Thumb Industries
$9.71 /

+0.13 (+1.36%)

08/04/22 Canaccord
Green Thumb Industries price target lowered to C$35 from C$40 at Canaccord
08/04/22 Stifel
Green Thumb Industries price target raised to C$30.50 from C$30 at Stifel
08/04/22 Alliance Global Partners
Green Thumb Industries price target lowered to C$25 at Alliance Global Partners
08/04/22 Cantor Fitzgerald
Green Thumb Industries price target lowered to $31 from $39 at Cantor Fitzgerald
IGC India Globalization Capital
/

+

TLRY Tilray
$3.85 /

-0.03 (-0.77%)

07/29/22 Cowen
Tilray price target lowered to $9 from $23 at Cowen
07/29/22 Benchmark
Tilray cut to Sell at Benchmark on continued deterioration in core business
07/29/22 Benchmark
Tilray downgraded to Sell from Hold at Benchmark
07/15/22 Roth Capital
Tilray price target lowered to $4 from $8 at Roth Capital
TCNNF Trulieve Cannabis
$13.30 /

-0.15 (-1.12%)

07/22/22 Seaport Global
Trulieve Cannabis initiated with a Buy at Seaport Global
05/12/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners
03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
ZYNE Zynerba
$1.22 /

+0.06 (+5.17%)

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
ATAI Atai Life Sciences
$4.10 /

+0.095 (+2.37%)

05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
CMPS Compass Pathways
$17.01 /

+0.93 (+5.78%)

08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
08/05/22 Citi
Compass Pathways price target lowered to $46 from $49 at Citi
02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
RLMD Relmada Therapeutics
$24.85 /

+0.22 (+0.89%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Securities
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
ZYNE Zynerba
$1.22 /

+0.06 (+5.17%)

TLRY Tilray
$3.85 /

-0.03 (-0.77%)

TCNNF Trulieve Cannabis
$13.30 /

-0.15 (-1.12%)

RLMD Relmada Therapeutics
$24.85 /

+0.22 (+0.89%)

GTBIF Green Thumb Industries
$9.71 /

+0.13 (+1.36%)

FLGC Flora Growth
/

+

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.39 /

-0.05 (-1.46%)

CMPS Compass Pathways
$17.01 /

+0.93 (+5.78%)

CLVR Clever Leaves
$1.01 /

+ (+0.00%)

CGC Canopy Growth
$2.84 /

-0.065 (-2.24%)

ATAI Atai Life Sciences
$4.10 /

+0.095 (+2.37%)

ACB Aurora Cannabis
$1.53 /

-0.015 (-0.97%)

  • 27
    May
  • 09
    Dec
  • 19
    Nov
ACB Aurora Cannabis
$1.53 /

-0.015 (-0.97%)

TLRY Tilray
$3.85 /

-0.03 (-0.77%)

TCNNF Trulieve Cannabis
$13.30 /

-0.15 (-1.12%)

LOVFF Cannara Biotech
/

+

FLGC Flora Growth
/

+

ETRGF Entourage Health
/

+

CRON Cronos Group
$3.39 /

-0.05 (-1.46%)

CLVR Clever Leaves
$1.01 /

+ (+0.00%)

CCHWF Columbia Care
$1.76 /

+0.015 (+0.86%)

ACB Aurora Cannabis
$1.53 /

-0.015 (-0.97%)

TLRY Tilray
$3.85 /

-0.03 (-0.77%)

CRON Cronos Group
$3.39 /

-0.05 (-1.46%)

CLVR Clever Leaves
$1.01 /

+ (+0.00%)

CGC Canopy Growth
$2.84 /

-0.065 (-2.24%)

ACB Aurora Cannabis
$1.53 /

-0.015 (-0.97%)

Hot Stocks
Columbia Care announces shareholder approval of Cresco Labs combination » 13:12
07/08/22
07/08
13:12
07/08/22
13:12
CCHWF

Columbia Care

$1.51 /

+0.06 (+4.14%)

, CRLBF

Cresco Labs

$3.06 /

+0.13 (+4.44%)

Columbia Care (CCHWF)…

Columbia Care (CCHWF) announced that at the special meeting of shareholders of the company, the proposed business combination with Cresco Labs (CRLBF) was approved. The Shareholders voted in favor of a special resolution to approve the previously announced plan of arrangement under the Business Corporations Act whereby, among other things, Cresco Labs will acquire all of the issued and outstanding shares of the Company, all as more particularly described in detail in the Company's definitive proxy statement and information circular dated June 6, 2022 filed on SEDAR and with the United States Securities and Exchange Commission. At the Meeting, a total of 169,938,646 Columbia Care Shares were represented in person or by proxy, representing 42.6% of the Columbia Care Shares issued and outstanding as of the close of business on May 10, 2022 and entitled to vote at the Meeting as of the Record Date.

ShowHide Related Items >><<
CCHWF Columbia Care
$1.51 /

+0.06 (+4.14%)

CCHWF Columbia Care
$1.51 /

+0.06 (+4.14%)

05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
CRLBF Cresco Labs
$3.06 /

+0.13 (+4.44%)

05/19/22 Canaccord
Cresco Labs price target lowered to C$9.50 from C$12 at Canaccord
05/19/22 Stifel
Cresco Labs price target lowered to C$5 from C$8 at Stifel
05/19/22 Alliance Global Partners
Cresco Labs price target lowered to C$15 from C$19 at Alliance Global Partners
03/25/22 Canaccord
Cresco Labs price target lowered to C$12 from C$15 at Canaccord
CCHWF Columbia Care
$1.51 /

+0.06 (+4.14%)

Over a quarter ago
Hot Stocks
Columbia Care operationalizes second cultivation facility in New Jersey » 07:25
06/07/22
06/07
07:25
06/07/22
07:25
CCHWF

Columbia Care

$1.73 /

-0.0706 (-3.92%)

Columbia Care announced…

Columbia Care announced it has started operations in its new, approximately 270,000-square-foot cultivation and production facility in New Jersey, begun using post-harvest automation equipment, and expanded its adult use shopping hours at both of its Cannabist locations in Deptford and Vineland to the maximum number of hours allotted by the New Jersey Cannabis Regulatory Commission, CRC.

ShowHide Related Items >><<
CCHWF Columbia Care
$1.73 /

-0.0706 (-3.92%)

CCHWF Columbia Care
$1.73 /

-0.0706 (-3.92%)

05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
CCHWF Columbia Care
$1.73 /

-0.0706 (-3.92%)

On The Fly
Rising High: Exclusive talk with cannabis company Tyson 2.0 » 11:42
05/26/22
05/26
11:42
05/26/22
11:42
CMPS

Compass Pathways

$7.97 /

+0.215 (+2.77%)

, ATAI

Atai Life Sciences

$4.01 /

+0.175 (+4.56%)

, RLMD

Relmada Therapeutics

$19.11 /

-0.08 (-0.42%)

, ZYNE

Zynerba

$1.01 /

+0.08 (+8.60%)

, TCNNF

Trulieve Cannabis

$14.12 /

-0.2871 (-1.99%)

, TLRY

Tilray

$4.63 /

+0.19 (+4.28%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$11.85 /

-0.24 (-1.99%)

, GDNSF

Goodness Growth

$1.53 /

+0.05 (+3.38%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.13 /

+0.085 (+2.79%)

, CGC

Canopy Growth

$5.35 /

+0.315 (+6.26%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$2.75 /

+0.07 (+2.62%)

, CCHWF

Columbia Care

$2.03 /

+0.05 (+2.53%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

TLRY Tilray
$4.63 /

+0.19 (+4.28%)

TCNNF Trulieve Cannabis
$14.12 /

-0.2871 (-1.99%)

RLMD Relmada Therapeutics
$19.11 /

-0.08 (-0.42%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.85 /

-0.24 (-1.99%)

GDNSF Goodness Growth
$1.53 /

+0.05 (+3.38%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

CCHWF Columbia Care
$2.03 /

+0.05 (+2.53%)

ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
RLMD Relmada Therapeutics
$19.11 /

-0.08 (-0.42%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Securities
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
TCNNF Trulieve Cannabis
$14.12 /

-0.2871 (-1.99%)

05/12/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners
03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
03/30/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners
TLRY Tilray
$4.63 /

+0.19 (+4.28%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.85 /

-0.24 (-1.99%)

05/05/22 Alliance Global Partners
Green Thumb price target lowered to C$38 from C$40 at Alliance Global
05/05/22 Craig-Hallum
Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum
05/05/22 Needham
Green Thumb Industries price target lowered to $26 from $33 at Needham
GDNSF Goodness Growth
$1.53 /

+0.05 (+3.38%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
CANN General Cannabis
/

+

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

05/20/22 Alliance Global Partners
Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners
04/04/22 Morgan Stanley
Constellation Brands price target lowered to $294 from $299 at Morgan Stanley
03/22/22 Barclays
Canopy Growth downgraded to Underweight from Equal Weight at Barclays
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
CCHWF Columbia Care
$2.03 /

+0.05 (+2.53%)

05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

TLRY Tilray
$4.63 /

+0.19 (+4.28%)

TCNNF Trulieve Cannabis
$14.12 /

-0.2871 (-1.99%)

RLMD Relmada Therapeutics
$19.11 /

-0.08 (-0.42%)

GTBIF Green Thumb Industries
$11.85 /

-0.24 (-1.99%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

  • 09
    Dec
  • 18
    Jun
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

CCHWF Columbia Care
$2.03 /

+0.05 (+2.53%)

TLRY Tilray
$4.63 /

+0.19 (+4.28%)

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

Recommendations
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord » 13:29
05/18/22
05/18
13:29
05/18/22
13:29
CCHWF

Columbia Care

$1.93 /

-0.02 (-1.03%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley lowered the firm's price target on Columbia Care to C$4.50 from C$6 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CCHWF Columbia Care
$1.93 /

-0.02 (-1.03%)

CCHWF Columbia Care
$1.93 /

-0.02 (-1.03%)

05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
11/15/21 Canaccord
Columbia Care price target lowered to C$13 from C$15 at Canaccord
CCHWF Columbia Care
$1.93 /

-0.02 (-1.03%)

Recommendations
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners » 16:33
05/16/22
05/16
16:33
05/16/22
16:33
CCHWF

Columbia Care

$1.95 /

+0.05 (+2.63%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey lowered the firm's price target on Columbia Care to C$8 from C$9 and keeps a Buy rating on the shares, noting that the company reported sales below his and Street estimates. Despite the sales miss, the company maintained its 2022 sales view, but continued consumer headwinds could cause sales to come in below current guidance, said Grey. However, he still views the company as well-positioned for the long-term given the company's assets in key U.S. states and the pending Cresco merger, Grey added.

ShowHide Related Items >><<
CCHWF Columbia Care
$1.95 /

+0.05 (+2.63%)

CCHWF Columbia Care
$1.95 /

+0.05 (+2.63%)

03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
11/15/21 Canaccord
Columbia Care price target lowered to C$13 from C$15 at Canaccord
08/27/21 Cantor Fitzgerald
Columbia Care upgraded to Overweight from Neutral at Cantor Fitzgerald
CCHWF Columbia Care
$1.95 /

+0.05 (+2.63%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.